Related Experiment Video
Updated: Mar 26, 2026
Novel And Efficient Method for Drosophila Heart Fluorescence Staining with Cryosectioning
Published on: March 28, 2025
SPARC-Dependent Cardiomyopathy in Drosophila
Paul S Hartley1, Khatereh Motamedchaboki2, Rolf Bodmer2
1From the Department of Life and Environmental Science, University of Bournemouth, Dorset, United Kingdom (P.S.H.); and Proteomics Facility (K.M.) and Development, Aging, and Regeneration Program (R.B., K.O.), Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA. phartley@bournemouth.ac.uk kocorr@sbpdiscovery.org.
Drosophila nephrocytes regulate heart function by secreting factors like SPARC. Reducing SPARC levels ameliorates cardiac dysfunction, suggesting a therapeutic target for human heart disease.
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Genetics
Background:
- The Drosophila heart serves as a model for mammalian cardiac function.
- Pericardial nephrocytes modulate heart function through poorly understood mechanisms.
- Understanding these mechanisms is crucial for human cardiac physiology.
Purpose of the Study:
- Identify cardiomodulatory factors secreted by Drosophila nephrocytes.
- Investigate the role of these factors in cardiac function.
- Determine relevance to human cardiac physiology.
Main Methods:
- Used a Kruppel-like factor 15 (dKlf15) loss-of-function strategy to ablate nephrocytes.
- Analyzed heart function and hemolymph proteome.
- Disrupted nephrocyte endocytic function and used temporal knockdown of dKlf15.
Main Results:
- Nephrocyte ablation caused severe cardiomyopathy with prolonged diastolic interval.
- Disrupted endocytosis or dKlf15 knockdown mimicked this cardiomyopathy.
- Proteomics identified Secreted Protein Acidic and Rich in Cysteine (SPARC) as a key regulated protein.
- Reducing SPARC gene dosage ameliorated the cardiomyopathy.
Conclusions:
- SPARC is implicated in the non-cell autonomous control of cardiac function in Drosophila.
- Modulating SPARC may offer a therapeutic strategy for human cardiac dysfunction.
